Nature Biotechnology
21, 613 - 617 (2003)
doi:10.1038/nbt0603-613
US venture capital for biotechnologyMark D Dibner1, Melanie Trull1
& Michael Howell21
M.D.D. and M.T. are at BioAbility, LLC, Research Triangle Park, NC 27709, USA
2
M.H. is at Curriculum in Neurobiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.
Correspondence should be addressed to Mark D Dibner mdibner@bioability.comA survey of US venture capital funds investing in biotechnology shows that the poor economy did not deter VC investment in biotechnology in 2002, but it is unclear what looms ahead.
|
